AAAAAA
Results: 1-25/83
Authors:
MIMRAN A
Citation: A. Mimran, RENAL ENDOTHELIAL FUNCTION IN HUMANS, Current opinion in nephrology and hypertension, 7(2), 1998, pp. 149-152
Authors:
MIMRAN A
RUILOPE L
KERWIN L
NYS M
OWENS D
KASSLERTAUB K
OSBAKKEN M
Citation: A. Mimran et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IRBESARTAN, WITH THE FULL DOSE RANGE OF ENALAPRIL FOR THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 12(3), 1998, pp. 203-208
Authors:
HALIMI JM
PHILIPPON C
MIMRAN A
Citation: Jm. Halimi et al., CONTRASTING RENAL EFFECTS OF NICOTINE IN SMOKERS AND NONSMOKERS, Nephrology, dialysis, transplantation, 13(4), 1998, pp. 940-944
Authors:
DEMEILLIERS B
JOVER B
MIMRAN A
Citation: B. Demeilliers et al., CONTRASTING RENAL EFFECTS OF CHRONIC ADMINISTRATIONS OF ENALAPRIL ANDLOSARTAN ON ONE-KIDNEY, ONE-CLIP HYPERTENSIVE RATS, Journal of hypertension, 16(7), 1998, pp. 1023-1029
Authors:
PASQUIE JL
HERIZI A
JOVER B
CAILAR G
MIMRAN A
Citation: Jl. Pasquie et al., EFFECT OF CHRONIC BRADYKININ INFUSION ON ANGIOTENSIN-II HYPERTENSION IN RATS, Journal of hypertension, 16(7), 1998, pp. 1057-1057
Authors:
JOVER B
DEMEILLIERS B
HERIZI A
MIMRAN A
Citation: B. Jover et al., RENAL ALTERATIONS IN N-G-NITRO-L-ARGININE METHYL-ESTER HYPERTENSION -INFLUENCE OF LOSARTAN AND BOSENTAN, Journal of hypertension, 16(7), 1998, pp. 1058-1058
Authors:
RIBSTEIN J
DUCAILAR G
MIMRAN A
Citation: J. Ribstein et al., INFLUENCE OF GLUCOSE-TOLERANCE ON THE AGE-ASSOCIATED DECLINE IN GLOMERULAR-FILTRATION RATE IN ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 123-123
Authors:
PASQUIE JL
HERIZI A
JOVER B
DUCAILAR G
MIMRAN A
Citation: Jl. Pasquie et al., EFFECT OF CHRONIC BRADYKININ INFUSION AND CHRONIC BRADYKININ-RECEPTORBLOCKADE ON CARDIAC-HYPERTROPHY IN ANGIOTENSIN II-TREATED RATS, Journal of hypertension, 16, 1998, pp. 141-141
Authors:
JOVER B
DEMEILLIERS B
HERIZI A
NISATO D
CAZAUBON C
MIMRAN A
Citation: B. Jover et al., IRBESARTAN BUT NOT ENALAPRIL REVERSES ALTERATION OF RENAL-FUNCTION ASSOCIATED WITH L-NAME HYPERTENSION, Journal of hypertension, 16, 1998, pp. 1534-1534
Authors:
RIBSTEIN J
DUCAILAR G
MIMRAN A
Citation: J. Ribstein et al., IS PRIMARY ALDOSTERONISM ASSOCIATED WITH HYPERFILTRATION, Journal of hypertension, 16, 1998, pp. 2415-2415
Authors:
DUCAILAR G
RIBSTEIN J
MIMRAN A
Citation: G. Ducailar et al., RELATIONSHIP BETWEEN HEART-RATE AND TARGET ORGAN DAMAGE AND ATHEROMATOUS RISK-FACTORS IN NEVER-TREATED ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 3321-3321
Authors:
MIMRAN A
CIFKOVA R
SANDOR S
WIECEK A
Citation: A. Mimran et al., ANTIHYPERTENSIVE EFFECT AND TOLERABILITY OF A LOW-DOSE COMBINATION OFCANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, Journal of hypertension, 16, 1998, pp. 31074-31074
Authors:
RIBSTEIN J
DUCAILAR G
MIMRAN A
Citation: J. Ribstein et al., RENAL-FUNCTION DECREASES WITH TIME IN UNTREATED HYPERTENSIVES, Hypertension, 32(4), 1998, pp. 8-8
Authors:
HERIZI A
JOVER B
BOURIQUET N
MIMRAN A
Citation: A. Herizi et al., PREVENTION OF THE CARDIOVASCULAR AND RENAL EFFECTS OF ANGIOTENSIN-II BY ENDOTHELIN BLOCKADE, Hypertension, 31(1), 1998, pp. 10-14
Authors:
MOURAD G
VELA C
RIBSTEIN J
MIMRAN A
Citation: G. Mourad et al., LONG-TERM IMPROVEMENT IN RENAL-FUNCTION AFTER CYCLOSPORINE REDUCTION IN RENAL-TRANSPLANT RECIPIENTS WITH HISTOLOGICALLY PROVEN CHRONIC CYCLOSPORINE NEPHROPATHY, Transplantation, 65(5), 1998, pp. 661-667
Authors:
JOVER B
CASELLAS D
MIMRAN A
NISATO D
CAZAUBON C
Citation: B. Jover et al., RENAL EFFECTS OF COMBINED TREATMENT BY IRBESARTAN AND ENALAPRIL IN L-NAME HYPERTENSION IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3825-3825
Authors:
ENGELBERG D
MIMRAN A
MARTINETTO H
OTTO J
SIMCHEN G
KARIN M
FINK GR
Citation: D. Engelberg et al., MULTICELLULAR STALK-LIKE STRUCTURES IN SACCHAROMYCES-CEREVISIAE, Journal of bacteriology, 180(15), 1998, pp. 3992-3996
Authors:
HOGLUND C
CIFKOVA R
MIMRAN A
TENCZER J
WATT A
WILKINS MR
LINDBERG E
Citation: C. Hoglund et al., A COMPARISON OF THE EFFECTS OF MIBEFRADIL AND ATENOLOL ON REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS, Cardiology, 89(4), 1998, pp. 263-270
Authors:
PASQUIE JL
HERIZI A
JOVER B
DUCAILAR G
MIMRAN A
Citation: Jl. Pasquie et al., EFFECT OF CHRONIC BRADYKININ INFUSION ON ANGIOTENSIN-II HYPERTENSION IN RATS, Archives des maladies du coeur et des vaisseaux, 91(8), 1998, pp. 1035-1038
Authors:
JOVER B
DEMEILLIERS B
HERIZI A
MIMRAN A
Citation: B. Jover et al., RENAL ALTERATIONS IN L-NAME HYPERTENSION - INFLUENCE OF LOSARTAN AND BOSENTAN, Archives des maladies du coeur et des vaisseaux, 91(8), 1998, pp. 1039-1042
Authors:
MIMRAN A
Citation: A. Mimran, MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION, Clinical and experimental hypertension, 19(5-6), 1997, pp. 753-767
Authors:
HERIZI A
DEMEILLIERS B
JOVER B
MIMRAN A
Citation: A. Herizi et al., CARDIOPROTECTIVE EFFECT OF ENALAPRIL IN RENOVASCULAR AND ANGIOTENSIN-II HYPERTENSION, Clinical and experimental hypertension, 19(5-6), 1997, pp. 953-964
Authors:
VELA C
CRISTOL JP
MAGGI MF
RIBSTEIN J
MIMRAN A
MOURAD G
Citation: C. Vela et al., ANTIOXIDANT VITAMIN-E SUPPLEMENTATION FOR THE CONTROL OF CHRONIC REJECTION IN RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 8, 1997, pp. 3285-3285
Authors:
PASQUIE JL
HERIZI A
JOVER B
DUCAILAR G
MIMRAN A
Citation: Jl. Pasquie et al., EFFECT OF CHRONIC BRADYKININ INFUSION AND CHRONIC BRADYKININ-RECEPTORBLOCKADE ON CARDIAC-HYPERTROPHY IN ANGIOTENSIN II-TREATED RATS, Journal of the American College of Cardiology, 29(2), 1997, pp. 3048-3048
Authors:
DUCAILAR G
RIBSTEIN J
MIMRAN A
Citation: G. Ducailar et al., CHRONIC INFLAMMATORY BOWEL-DISEASE, La Revue de medecine interne, 18, 1997, pp. 295-298